Clinical Trials Browser

Phase 2/3 × OTHER × Gynecologic × Clear all

NCT07319429 2026-03-13

FEMUS

Phase 2/3 Recruiting

Endometrial Neoplasms

NCT07440290 2026-02-27

DETERMINE

Phase 2/3 Not yet recruiting

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT07298642 2025-12-23

Extended-field Proton Therapy for Cervical Cancer

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT03651206 2025-12-19

ROCSAN

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

NCT05381597 2025-11-28

5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer

Phase 2/3 Recruiting

Squamous Intraepithelial Lesions

NCT05768178 2025-11-24

DETERMINE

Phase 2/3 Recruiting

CNSDermatologicEndocrineGastrointestinalGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Glioma, Laryngeal Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT04159155 2025-08-12

CAN-STAMP

Phase 2/3 Terminated

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT05316467 2025-08-11

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Phase 2/3 Recruiting

GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT06791460 2025-03-18

Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer

Phase 2/3 Recruiting

Ovarian Cancer Recurrent

NCT01554397 2024-11-29

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

Phase 2/3 Completed

101 enrolled 13 charts

Carcinoma, Uterine Cervical Neoplasms

NCT05255653 2024-11-29

RAINBO

Phase 2/3 Recruiting

Endometrial Neoplasms

NCT02758951 2024-11-25

CAIRO6

Phase 2/3 Active not recruiting

GastrointestinalGynecologic

Hyperthermia, Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT06288373 2024-10-30

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT06227676 2024-04-12

NUTRITION; GYN

Phase 2/3 Completed

Dysmenorrhea, Menstruation Disturbances, Muscle Cramp, Ovarian Cysts, Polycystic Ovary Syndrome, Premenstrual Syndrome, Premenstrual Dysphoric Disorder

NCT06341907 2024-04-02

Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC

Phase 2/3 Recruiting

Carcinoma, Ovarian Epithelial

NCT03458221 2023-04-18

STAPOVER

Phase 2/3 Recruiting

Ovarian Neoplasms, Neoplasms, Second Primary

NCT05489848 2022-08-05

Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation

Phase 2/3 Not yet recruiting

Endometrial Neoplasms

NCT04795596 2022-04-15

Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers

Phase 2/3 Withdrawn

Ovarian Neoplasms

NCT03668639 2021-12-14

Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

Phase 2/3 Unknown

Uterine Cervical Neoplasms, Vomiting

NCT05149248 2021-12-08

CONDESA

Phase 2/3 Completed

Uterine Cervical Neoplasms, Neoplasms

NCT03285802 2020-02-05

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Phase 2/3 Completed

Uterine Neoplasms

NCT04055038 2019-08-13

EPITOC

Phase 2/3 Unknown

Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT03885388 2019-03-21

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6

Phase 2/3 Unknown

Gestational Trophoblastic Disease, Drug-Related Side Effects and Adverse Reactions

NCT03357640 2017-11-30

Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?

Phase 2/3 Unknown

Ovarian Cysts

NCT03280979 2017-09-13

Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia

Phase 2/3 Unknown

Gestational Trophoblastic Disease

NCT03163979 2017-05-23

PROGRAMMA

Phase 2/3 Unknown

Uterine Cervical Neoplasms

NCT02606539 2017-03-22

SVCGTN

Phase 2/3 Unknown

Gestational Trophoblastic Disease

NCT01196741 2015-05-05

SaPPrOC

Phase 2/3 Completed

107 enrolled 17 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01095198 2011-07-21

Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)

Phase 2/3 Unknown

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT00941252 2011-01-24

ITIC

Phase 2/3 Completed

Uterine Cervical Dysplasia